title: Tumor markers and colorectal cancer: utility in management.
abstract: Colorectal cancer (CRC) is a leading cause of morbidity and mortality. Although genetic testing can screen for rare hereditary CRC syndromes, there is no ideal means of screening for sporadic forms of CRC. This review will focus on markers that are currently used in the management of sporadic CRC and their limitations, as well as possible future clinical applications.
authors.affiliation: Price Institute of Surgical Research, Department of Surgery, University of Louisville, Kentucky 40292, USA.
authors.forename: Nigel P S
authors.initials: NP
authors.lastname: Crawford
authors.forename: Daniel W
authors.initials: DW
authors.lastname: Colliver
authors.forename: Susan
authors.initials: S
authors.lastname: Galandiuk
mesh_terms: D011125:Adenomatous Polyposis Coli / Q000175:diagnosis / Q000235:genetics; D000911:Antibodies, Monoclonal / Q000276:immunology; D014408:Biomarkers, Tumor / Q000097:blood*; D019496:Cancer Vaccines / Q000627:therapeutic use; D002272:Carcinoembryonic Antigen / Q000097:blood; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000628:therapy; D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000175:diagnosis; D005819:Genetic Markers; D006801:Humans; D009780:Occult Blood; D009955:Ornithine Decarboxylase / Q000097:blood; D011379:Prognosis; D016719:Radioimmunodetection
chemical_list: D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor; D019496:Cancer Vaccines; D002272:Carcinoembryonic Antigen; D005819:Genetic Markers; D009955:Ornithine Decarboxylase